CAPR vs LDOS · $1.62B cap vs P/E 16, rev $8.96B
Capricor Therapeutics Inc (CAPR) versus Leidos Holdings Inc (LDOS) — a side-by-side from cached financials, not a winner call.
Capricor Therapeutics Inc (CAPR) is a biotechnology company listed on NASDAQ.
Leidos Holdings Inc (LDOS) is a information technology services company listed on US.
Latest reported CAPR revenue for 2025-12-31 was $0. Net income was -$105.0M. CAPR currently screens at market cap $1.62B.
Latest reported LDOS revenue for 2026-07-03 was $8.96B. Net income was $682.0M. LDOS currently screens at market cap $20.04B and trailing P/E 15.7.
CAPR currently screens at market cap $1.62B. LDOS currently screens at market cap $20.04B and trailing P/E 15.7.
Not investment advice. Open the CAPR and LDOS stock pages for the full models.
Not investment advice.